Sarm1 Gates the Transition from Protective to Repair Schwann Cell States Following Nerve Injury

This study identifies Sarm1 as a critical regulator that gates the transition of Schwann cells from a protective state to a repair state following nerve injury, where its deletion enhances axon protection and maintains a distinct gene expression profile associated with developmental myelin preservation.

The Gist

The Big Picture: A Traffic Cop at the Scene of a Crash

Imagine your peripheral nerves (the cables running from your spine to your hands and feet) are like a busy highway. The Schwann Cells are the road crews and maintenance workers who live alongside these cables. When a nerve gets cut or injured (a car crash), these workers have a very specific job to do: they need to clear the debris and help the cable repair itself.

For a long time, scientists thought the road crew just waited for the signal to start working. But this new study discovered that the road crew actually has a two-step emergency plan, and there is a specific "traffic cop" inside the crew that decides when to switch from Step 1 to Step 2.

That traffic cop is a protein called Sarm1.

The Story Unfolds

1. The "Protective" Phase (The PASC State)

When a nerve is first injured, the Schwann cells don't immediately jump into "repair mode." Instead, they enter a temporary, special state the authors call PASC (Protection-Associated Schwann Cell).

• What they do: In this state, the cells act like a protective shield. They pump out nutrients and safety factors to keep the damaged nerve cable from falling apart completely. They are essentially saying, "Hold on, let's see if we can save this cable before we start the heavy demolition."
• The Problem: This protective state is very short-lived. If it lasts too long, the nerve cable eventually dies anyway. The cells need to switch gears quickly to start the actual rebuilding process.

2. The "Repair" Phase

After a few hours, the Schwann cells are supposed to switch to the Repair State.

• What they do: They start eating up the broken myelin (the insulation around the nerve), clearing the trash, and building a tunnel (called a "band of Büngner") to guide the nerve cable as it grows back.

3. Enter the Traffic Cop: Sarm1

The study found that Sarm1 is the protein that acts as the gatekeeper between these two phases.

• In a normal (Wild Type) nerve: Sarm1 is present. It lets the cells stay in the "Protective" phase for a little while, but then it forces them to switch to the "Repair" phase. This is necessary for long-term healing.
• The Twist: The researchers found that Sarm1 actually hurts the nerve in the very early hours. It helps the nerve cable degenerate (break down) faster.

The Experiments: What Happened When They Turned Off the Cop?

The scientists decided to see what happens if they remove Sarm1 from the Schwann cells (the road crew) in mice and even in fruit flies.

• The Result: Without Sarm1, the Schwann cells got "stuck" in the Protective Phase. They refused to switch to the Repair Phase.
• The Good News: Because they stayed in the protective mode longer, the nerve cables were much better protected. They didn't break down as quickly. In the fruit fly experiments, removing the "cop" from the glial cells (the fly version of road crews) saved the nerve cables from breaking for hours.
• The Bad News: Because they were stuck in "protection mode," they were slow to start the actual "repair mode." While the nerve survived longer initially, it might have trouble regenerating later because the cleanup crew didn't start their job on time.

The Metaphor: The "Firefighter" vs. The "Demolition Crew"

Think of a nerve injury like a building on fire.

1. The Injury: The building catches fire.
2. The PASC State (Protective): The firefighters (Schwann cells) arrive. Their first job is to save the people inside (the nerve axon). They spray water and create a shield to stop the fire from spreading immediately.
3. The Sarm1 Protein: This is the Fire Chief.
   • Normal Scenario: The Chief says, "Okay, we've saved the people for a few minutes. Now, stop spraying water and start tearing down the burnt walls so we can rebuild!" (Switch to Repair).
   • The Study's Finding: The Chief (Sarm1) actually helps the building burn down a bit faster to make room for the new one. If you fire the Chief (remove Sarm1), the firefighters keep spraying water and protecting the building for a long time. The building stays standing longer (axon protection), but the demolition crew never shows up to clear the rubble for the new construction.

Why Does This Matter?

This discovery changes how we think about treating nerve injuries.

• The Dilemma: We want to stop nerves from dying immediately after an injury (which Sarm1 removal helps with), but we also need them to regenerate later (which requires Sarm1 to be active).
• The Solution: The authors suggest that maybe we don't need to block Sarm1 forever. Instead, we might be able to use a "pulsed" therapy.
  • Step 1: Give a drug to block Sarm1 immediately after an injury. This keeps the nerve safe and alive (the "Protective" phase).
  • Step 2: Once the nerve is safe, stop the drug. This allows Sarm1 to wake up and tell the cells to switch to "Repair" mode so the nerve can grow back.

Summary

This paper discovered that Schwann cells have a hidden "protective mode" that happens right after a nerve injury. A protein called Sarm1 acts as a switch that turns this protective mode off and turns the "repair mode" on. If you turn off Sarm1, the nerve stays safe longer, but the repair process gets delayed. This gives doctors a new idea: maybe we can time our treatments to keep nerves safe first, and then help them heal later.

Technical Summary

1. Problem Statement

Following peripheral nerve injury, Schwann cells (SCs) undergo a phenotypic switch from a myelinating state to a "Repair" state, characterized by the upregulation of regeneration-associated genes (e.g., c-Jun) and myelin clearance. While the repair state is well-characterized, the immediate transcriptional and functional events occurring in SCs during the first few hours post-injury—specifically before the canonical repair program and the glycolytic shift (driven by mTORC1) are fully established—remain poorly understood.

Furthermore, Sarm1 (Sterile Alpha and TIR Motif Containing 1) is a well-established executioner of axonal degeneration, acting cell-autonomously within neurons to deplete NAD+ and trigger Wallerian degeneration. However, its role in non-neuronal cells, specifically SCs, and whether SC-intrinsic Sarm1 contributes to axon degeneration non-cell-autonomously, has not been fully elucidated.

2. Methodology

The authors employed a multi-modal approach combining in vitro models, in vivo mouse genetics, Drosophila models, and single-nucleus RNA sequencing (snRNA-seq).

• In Vitro Models:

  • Microfluidic Co-culture: Superior Cervical Ganglion (SCG) neurons were co-cultured with Wild-Type (WT) or Sarm1 knockout (KO) SCs in microfluidic devices to spatially separate cell bodies from axons. Axotomy was induced by removing cell bodies, and axon degeneration was quantified at 6 and 8 hours.
  • SC Culture: Primary SCs were isolated and treated with Neuregulin 1 (Nrg1) to mimic injury signaling. Mitochondrial respiration was assessed via Seahorse XFe96 analyzer (OCR measurements).

• In Vivo Mouse Models:

  • Conditional Knockout: Mice with Sarm1 floxed alleles were crossed with Sox10-Cre mice to generate SC-specific Sarm1 conditional knockouts (CKO).
  • Injury Model: Sciatic nerve transection was performed. Axon degeneration was assessed at 48 hours via Transmission Electron Microscopy (TEM).
  • snRNA-seq: Sciatic nerves from WT and Sarm1 KO mice were harvested at Sham, 2 hours post-injury (2hpi), and 1 day post-injury (1dpi). Nuclei were isolated, FACS-sorted, and sequenced using 10x Genomics.

• Drosophila Model:

  • Wing Injury: A wing transection model was used to ablate neuronal cell bodies. Glial-specific knockdown of dSarm (using Repo-Gal4) was performed to test evolutionary conservation of the glial role in axon degeneration.

• Molecular Techniques:

  • RNA FISH: Used to detect Sarm1 transcripts within Sox10+ SC nuclei in situ.
  • Bioinformatics: Pseudobulk differential expression analysis, Gene Ontology (GO) enrichment, KEGG pathway analysis, and pseudotime trajectory analysis (Monocle3) were performed on snRNA-seq data.

3. Key Contributions & Results

A. Sarm1 is Expressed and Upregulated in SCs

• Expression: Sarm1 mRNA is detected in ~19% of Sox10+ SC nuclei in uninjured nerves and increases in transcript number per cell after injury.
• Autonomy: Cultured SCs from WT mice express Sarm1, which is absent in Sarm1 KO cultures, confirming SC-autonomous expression.

B. SC-Derived Sarm1 Promotes Axon Degeneration (Non-Cell-Autonomous)

• In Vitro: SCG neurons co-cultured with Sarm1 KO SCs showed significantly delayed axon degeneration (26.8% reduction at 8h) compared to WT SCs.
• In Vivo (Mouse): At 48 hours post-sciatic nerve transection, SC-specific Sarm1 CKO mice exhibited only 6.7% axon degeneration, compared to 21% in controls.
• In Vivo (Fly): Glial-specific knockdown of dSarm in Drosophila wing nerves significantly reduced axonal breaks and puncta at 8 hours post-injury.
• Conclusion: Sarm1 acts within glia/SCs to accelerate axon degeneration, a function conserved from flies to mammals and independent of myelination status.

C. Discovery of the "Protection-Associated Schwann Cell" (PASC) State

• Transcriptomic Profiling: snRNA-seq revealed that Sarm1 KO SCs at 1dpi are enriched in a distinct cluster (sc4) that is rarely populated by WT SCs at this timepoint.
• PASC Characteristics:
  • Intermediate State: Pseudotime analysis places cluster sc4 as an intermediate state between homeostatic SCs and the canonical "Repair" SCs (clusters sc1/sc6).
  • Gene Signature: Enriched for genes involved in myelin formation and axon protection (Ptgds, Ptprd, Trf, Fth1) and oxidative phosphorylation.
  • Metabolic Shift: Unlike WT SCs, which downregulate mitochondrial respiration genes post-injury, Sarm1 KO SCs upregulate oxidative phosphorylation genes (e.g., Ndufb10, Cox5b). This was validated by RNA FISH and Seahorse assays showing increased maximal OCR in Sarm1 KO SCs.
• The "Gate" Hypothesis: The authors propose that Sarm1 acts as a molecular gate. In WT animals, SCs rapidly transition through the transient PASC state to the Repair state. In Sarm1 KO animals, this transition is delayed/bottlenecked, causing SCs to accumulate in the protective PASC state.

D. Temporal Dynamics

• Early Phase (0–24h): Sarm1-dependent mechanisms drive the transition from PASC to Repair. Loss of Sarm1 extends the window of axonal protection provided by the PASC state.
• Late Phase (Days): While PASC maintenance offers short-term protection, the delay in entering the Repair state (characterized by c-Jun upregulation and myelin clearance) may impair long-term regeneration, consistent with previous findings that Sarm1 KO mice have delayed regeneration.

4. Significance and Implications

• Novel Cell State: The study defines a previously uncharacterized, transient SC state (PASC) that serves as a checkpoint for axonal survival immediately following injury.
• Mechanism of Degeneration: It establishes that axon degeneration is not solely a neuronal cell-autonomous process; glial Sarm1 actively contributes to the "acceleration" of degeneration in the acute phase.
• Therapeutic Potential:
  • Timing is Critical: Systemic Sarm1 inhibition might be beneficial acutely (by prolonging the protective PASC state and preventing early degeneration) but detrimental long-term (by blocking the transition to the Repair state necessary for regeneration).
  • Strategy: The authors suggest that "pulsed" or reversible Sarm1 inhibition, or combinatorial therapies that stabilize PASCs while simultaneously activating Repair pathways (e.g., via c-Jun), could optimize nerve recovery.
• Metabolic Regulation: The findings highlight a complex metabolic reprogramming in SCs post-injury, where Sarm1 loss shifts the balance toward oxidative phosphorylation, contrasting with the glycolytic shift observed in WT SCs at later timepoints.

In summary, this paper redefines the role of Sarm1 in the peripheral nervous system, identifying it as a critical regulator of the timing and metabolic state of Schwann cell responses to injury, with profound implications for treating peripheral neuropathies and neurodegenerative diseases.